OnKAI is a healthcare startup that aims to address health equity gaps for underserved patients in the United States. Founded in 2018, the company's slogan "Solving #health equity gaps to improve the lives of #underserved #patients" encapsulates its core mission. OnKAI leverages the HelloKai Smart GridTM, an innovative solution that uses AI-based algorithms to proactively identify healthcare needs and connect them with available resources to improve care outcomes.
The company has received a $6.00M Corporate Round investment from Galmed Pharmaceuticals in May 4, 2023. OnKAI operates at the intersection of Blockchain and Health Care industries, aligning with the growing trend of leveraging technology for healthcare improvement. By connecting health ecosystem players, providers, product innovators, and foundations, OnKAI aims to revolutionize the provision of healthcare for underserved populations.
With its innovative approach and support from Galmed Pharmaceuticals, OnKAI is well-positioned to not only address critical healthcare gaps but also make a significant impact on underserved communities. OnKAI's emphasis on equal, high-quality, innovative, and affordable healthcare aligns with the increasing focus on health equity, making it a promising venture for potential investors seeking to support impactful healthcare initiatives.